The Latest Breaking News from Artivion

Top US heart surgery device maker hit by ransomware attack

Artivion confirms security breach in new 8-K filing, saying the investigation is ongoing.

TechRadar · Dec 10, 2024

Recap of Wednesday's Biotech Catalysts - End of The Day Summary

IDEAYA Biosciences (NASDAQ:IDYA) has entered into a clinical trial collaboration and supply agreement with Amgen Inc. to evaluate the efficacy and safety of IDE397 with Amgen's AMG 193  in a Phase 1 clinical trial. IDEAYA shares traded in a range of $14.59 to $15.82 on a day volume of 130.58…

Benzinga · Jul 27, 2022

Recap: Artivion Q4 Earnings

Artivion (NYSE:AORT) reported its Q4 earnings results on Thursday, February 17, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Artivion missed estimated earnings by 100.0%, reporting an EPS of $0.0 versus an estimate of $-0.06.

Benzinga · Feb 17, 2022